CAR (Chimeric Antigen Receptor) T-Cell Therapy: Immuno-Oncology, Immunomodulation, and Immunotherapy in Cancer

Cancer is one of the main sources of death around the world. Throughout the long term, several traditional cytotoxic methodologies for neoplastic illnesses have been created. Notwithstanding, because of their restricted adequacy as per the heterogeneity of malignant growth cells, there is a steady quest for helpful methodologies with the improved result, for example, an immunotherapy that uses furthermore, improves the ordinary limit of the patient's resistant malignancy

Author(s):

Vikas Kumar Maurya

Abstract | PDF

Share this